![Jean-Pierre Julien](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jean-Pierre Julien
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ImStar Therapeutics, Inc.
![]() ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | 01-01-2012 | - |
Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | - | |
Oprichter | 01-01-2012 | - |
Loopbaan van Jean-Pierre Julien
Statistieken
Internationaal
Canada | 2 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ImStar Therapeutics, Inc.
![]() ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Jean-Pierre Julien
- Ervaring